RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Allergan Inc.

A collection of news and information related to Allergan Inc. published by this site and its partners.

Top Allergan Inc. Articles

Displaying items 23-33
  • Allergan rejects Valeant's takeover bid, but it's probably not over

    Botox maker Allergan Inc. rejected a $46-billion takeover offer from a Canadian rival, setting the stage for what analysts said may become a long and nasty fight for control of the Irvine company and its prized collection of eye and skin medications....
  • Valeant to increase bid for Allergan

    Valeant to increase bid for Allergan
    The stakes for Botox maker Allergan Inc. just got higher. Valeant Pharmaceutical International Inc. said it intends to raise its bid for Allergan, one day after the Irvine company defiantly rejected its initial offer as too low. In a letter to...
  • Ackman wants shareholders to push Allergan into takeover talks

    Activist investor Bill Ackman wants Allergan Inc. shareholders to vote on a resolution that would encourage the Botox maker to meet with its potential acquirer, Valeant Pharmaceuticals International Inc. In a filing Tuesday with the Securities and...
  • Valeant Pharmaceuticals vows to boost its $46-billion bid for Allergan

    The heated takeover fight over Allergan Inc., the maker of Botox, continued Tuesday with the Canadian pharmaceutical company Valeant vowing to increase its $46-billion offer this month. Meanwhile, the Canadian firm's partner in the offer, activist...
  • Zimmer to buy Biomet amid flurry of billion-dollar medical deals

    Zimmer to buy Biomet amid flurry of billion-dollar medical deals
    Orthopedic products maker Zimmer Holdings on Thursday announced it will acquire Biomet Inc. in a deal valued at $13.35 billion, including assumption of debt, the companies said.    The proposed acquisition follows a flurry of billion-dollar deals by...
  • Ackman, Valeant partnering in bid to acquire Botox maker Allergan

    Ackman, Valeant partnering in bid to acquire Botox maker Allergan
    Activist investor Bill Ackman is partnering with Valeant Pharmaceuticals in an attempt to buy Orange County pharmaceutical company Allergan Inc., which sells the popular wrinkle treatment Botox. Ackman’s Pershing Square Capital Management said...
  • Ackman, Valeant partner in bid to buy Botox maker Allergan

    Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox. Ackman and Valeant Pharmaceuticals International Inc. have already...
  • Ackman and Valeant make bid for Allergan

    Ackman and Valeant make bid for Allergan
    Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle treatment. Valeant will...
  • Novartis, GSK announce multibillion-dollar overhaul of drug businesses

    Novartis, GSK announce multibillion-dollar overhaul of drug businesses
    Swiss pharmaceutical titan Novartis AG on Tuesday announced an overhaul of its operations that involved several multibillion-dollar deals with GlaxoSmithKline intended to allow Novartis to focus on its oncology business and boost profitability, the...
  • Allergan says it 'will carefully review' Valeant offer

    Allergan says it 'will carefully review' Valeant offer
    Allergan Inc., the Irvine company that makes popular wrinkle treatment Botox, acknowledged Tuesday that it has received a buyout offer from Valeant Pharmaceuticals International Inc. The company said the offer from the Canadian drug maker was...
  • Allergan stock climbs amid $46-billion bid

    Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....